$BMY

AI Analysis

Generated on May 11, 2026

AI Score
66/ 100
Hold$BMY

Bristol-Myers Squibb

$BMYNYSEHealthcareLarge-Cap

Bristol-Myers Squibb discovers, develops, and delivers innovative medicines for serious diseases including cancer, cardiovascular, and immunology.

Market Cap
$100.0B
Revenue (TTM)
$45.0B
+3.0%
Net Income (TTM)
$8.0B
-5.0%
EPS (TTM)
$3.85
P/E Ratio
12.0
Dividend Yield
4.5%
52-Week Range
$40-$58
Beta
0.52
Dimension Scores
Fundamental
68
Technical
60
Sentiment
64
Risk / Reward
72
Momentum
54
FundTechSentRiskMome
Financial Health
Profitability
73moderate
Growth
57moderate
Liquidity
80strong
Solvency
70strong
Efficiency
66strong

Valuation, technical analysis, investment thesis, risk assessment and more for $BMY

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.